Consequently, top 6 targets, AKT1, interleukin-6 (IL-6), CAT, Tumor necrosis factor (TNF), CASP3, and PTGS2, were predicted to be the key targets of P. lactiflora in the treatment of PD. Here, PTGS2 is linked to Parkinson disease.